Rorer Report issue

For profit Phase 3
Founded: Fort Washington PA United States (1910)
Status: Acquired by Rhone-Poulenc Rorer (1990) → now Sanofi-Aventis (2004)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1983
nitroglycerin (transderm-nitro)
First NDA Approval
None
Last Known Activity
1983

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

RORER

Active Ingredients

Marketed Drugs (1)

nitroglycerin (transderm-nitro) (1983)

Drugs in Phase 3 Trials (2)

Key: Rorer (0) Acquired (2)

atorvastatin (lipitor) (1 trial)

levocarnitine (carnitor) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 2